Diabetes
News
FDA okays triple-combo pill for type 2 diabetes
The once-daily therapy comprises the well-established medications empagliflozin, linagliptin, and metformin.
From the Journals
Barbers have role in encouraging diabetes screening in black men
Blood glucose testing offered to black men attending black-owned barbershops could help identify those with undiagnosed diabetes.
Feature
What will it take to lower the cost of insulin in the United States?
Government reforms and the involvement of nongovernmental organizations in price oversight and generic manufacturing are among the possible...
News
FDA approves CV disease benefit for once-weekly semaglutide
The approval was based on data from the SUSTAIN 6 in patients with type 2 diabetes and established heart disease.
Conference Coverage
Sarcopenia associated with increased cardiometabolic risk
LOS ANGELES – Loss of lean body mass and function with aging reduces metabolically active tissue, which can lead to...
Conference Coverage
Bariatric surgery is most effective early in the diabetes trajectory
LOS ANGELES – But in the United States, only about 1% of eligible patients with diabetes undergo the procedure.
News
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.
From the Journals
Gout rates reduced with SGLT2 inhibitors
Type 2 diabetes patients using SGLT2 inhibitors had significantly lower rates of gout than did those taking GLP1 agonists.
Conference Coverage
Treatment of heart failure with preserved ejection fraction is a work in progress
Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care...
Conference Coverage
Diabetes boosts bariatric surgery complications
LAS VEGAS – In addition, patients with insulin-dependent diabetes had significantly higher rates of these and other complications, compared with...
Conference Coverage
Carbohydrate restriction a viable choice for reversal of type 2 diabetes, expert says
LOS ANGELES – Even patients who did not experience a reversal had reductions in HbA1c and triglyceride...